Re: Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.
0/5 보강
APA
Kawahara T (2025). Re: Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.. International journal of urology : official journal of the Japanese Urological Association, 32(12), 1862-1863. https://doi.org/10.1111/iju.70259
MLA
Kawahara T. "Re: Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.." International journal of urology : official journal of the Japanese Urological Association, vol. 32, no. 12, 2025, pp. 1862-1863.
PMID
41090477 ↗
같은 제1저자의 인용 많은 논문 (5)
- [Recent Progress in Novel Therapies for Non-Muscle Invasive Bladder Cancer].
- Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study.
- Illustrating Implications of Misaligned Causal Questions and Statistics in Settings With Competing Events and Interest in Treatment Mechanisms.
- Patients' Preferences and the Time to Finish Gonadotropin-Releasing Hormone (GnRH) Agonist and Antagonist Injections in Japanese Prostate Cancer Patients.
- Cerebral Infarction by Paradoxical Gas Embolism During Laparoscopic Liver Resection with Injury of the Hepatic Vessels in a Patient without a Right-to-Left Systemic Shunt.